Our Chief Innovator
Mir Imran founded InCube Labs to focus on his passion: creating medical solutions that change the standard of care in critical healthcare markets. After attending medical school, Mir began his career as a healthcare entrepreneur in the late 1970’s and has founded numerous game-changing companies since those early days.MORE ON MIR
InCube Labs’ team has expertise across a range of disciplines: pharmacology and physiology, protein and polymer chemistry, tissue engineering, mechanical engineering and material science, electronics and software, industrial design, clinical development and manufacturing. Our leadership team also has deep experience in company building and commercializing innovations.
Chairman & CEO
Mir ImranChairman & CEO
Mir Imran is a prolific healthcare innovator and entrepreneur who has been developing and commercializing breakthrough medical innovations for more than 40 years. Since 1995, Mir’s innovations have been developed at his life science R&D lab and incubator, InCube Labs. As an entrepreneur, Mir has founded more than 20 life sciences companies; 15 of his companies have seen “liquidity events” (IPO/Acquisition). Mir now holds more than 400 issued patents and is perhaps most well-known for his pioneering contributions to the first FDA-approved Automatic Implantable Cardioverter Defibrillator. Mir has received a number of industry accolades for his work including being named one of the most inspiring people in life sciences (PharmaVoice) and one of the “Top 50 Medical Device Inventors of All Time” (QMed). Mir has also been recognized as a fellow for both the National Academy of Inventors (NAI) and the National Academy of Engineering (NAE). He holds an M.S. in bioengineering and a B.S. in electrical engineering from Rutgers. Mir also attended CMDNJ/Rutgers Medical School. In addition to leading InCube Labs, Mir is also the Chairman and CEO of InCube company, Rani Therapeutics.
Vice President, R&D
Mir HashimVice President, R&D
Mir Hashim brings more than 30 years of pharmaceutical research and development experience to InCube Labs, including leadership and management of a multi-laboratory, multi-group, pharmacology section. His breadth of knowledge and experience in pharmacology and physiology spans a variety of therapeutic areas including CNS, cardiovascular, gastrointestinal, anesthesia, and metabolic diseases such as diabetes and obesity. Prior to InCube, Mir spent 18 years at Glaxo Smith Kline where he most recently served as the head of Pharmacology. Mir has deep experience in drug discovery and development, international regulatory submissions, international product development, as well as in-licensing and out-licensing of drug candidates. Mir holds a B.S. in Biology and Chemistry from Osmania University, India; an M.S. in Biology from Central University of Hyderabad, India, as well as a PhD in Medicine/Pharmacology from Memorial University, St. John’s, Canada.
Vice President, Business Development
Stephanie McGroryVice President, Business Development
Stephanie has more than 25 years of marketing, communications and business management experience. In her role, Stephanie is responsible for business development, including negotiations of collaborations and licensing deals and managing ongoing partner relationships. In addition to her business development role, Stephanie manages communications and marketing programs for InCube and its portfolio companies. Prior to joining InCube in 2009, Stephanie was a founder and Executive Vice President for Greenough Communications, a nationally-recognized marketing services firm, where she managed client service operations, new business and staff development. Stephanie graduated from the College of the Holy Cross with a BA in English.
Vice President (San Antonio)
Phil MorganVice President (San Antonio)
Phil Morgan brings more than 25 years of pharmaceutical research and development experience to InCube Labs and has extensive experience in drug development and the regulatory approval process.
He was the pre-clinical pharmacology expert for several drugs including Wellbutrin SR and Zyban. Prior to joining InCube Labs, Phil co-founded several successful life science companies and served as the president and CEO of Cytospect, Cytoscan and Neurotherapeutics.
Before that, he was the Head of the Department of Molecular Pharmacology and a Senior Scientist at GlaxoSmithKline and a Visiting Fellow and Scientist at the National Institutes of Health, Bethesda, MD. Phil has published over 50 peer-reviewed articles and holds a PhD from London University and an MBA from Duke University.
Vice President, Intellectual Property
Angela MurchVice President, Intellectual Property
Angela brings more than fifteen years of experience in engineering and eight years of experience in the legal profession to InCube. Angela has experience in patent prosecution and litigation across various technologies, such as medical devices and systems, robots and robotic systems, optics, signal processing and circuitry, wireless power transfer devices and systems, and control systems, to name a few. Prior to entering the field of law, Angela was a hardware engineer and project lead for electronics control units; a project lead for a power stage integrated circuit; a core system engineering design and support specialist; a microcontroller specialist; and an engineering specialist in an advanced electrical architecture group. In the space industry, Angela was responsible for various analog and digital electronics on the space shuttle solid rocket booster. Angela earned her law degree, cum laude, at Wayne State University Law School where she served on the Wayne Law Review, was a Dean’s Scholar and Lombard Fellow, and was elected by faculty to the Order of the Coif. Angela holds a master’s degree in electrical engineering from the University of Michigan and a bachelor’s degree in electrical engineering from Michigan State University. She is a member of Tau Beta Pi engineering honor fraternity and Eta Kappa Nu electrical engineering honor fraternity. Angela is a licensed attorney in the state of California and is registered to practice before the United States Patent and Trademark Office (USPTO).
Vice President (San Antonio)
Pratap KhanwilkarVice President (San Antonio)
Pratap has more than 30 years of experience as a serial medtech entrepreneur. Pratap has founded eight companies and has several patents to his name. Prior to joining InCube, Pratap was the founding Coulter Program Director, Professor and Executive-In-Residence at the University of Pittsburgh. There he led the [email protected] Research program to become one of the most productive and emulated in the country.
Pratap leads InCube’s product development, including engineering, manufacturing development and quality assurance, and helps develop and implement pre-clinical and clinical studies. He also promotes the growth and evolution of InCube’s San Antonio facilities, including related University and Community relations. Pratap received his undergraduate degree in Electrical Engineering from the Indian Institute of Technology, and his graduate degrees (MS, PhD in Bioengineering, MBA) are from the University of Utah. He is a Fellow of the American Institute for Medical & Biological Engineering.
Vice President, Finance & Accounting
Gary DangVice President, Finance & Accounting
Gary has more than 30 years in tax and business consulting experience as a Certified Public Accountant. Most recently, he was the Lead Tax Partner in the Silicon Valley office of SingerLewak, LLP, a regional CPA firm with approximately 300 employees. Gary’s clientele consisted of closely held businesses, as well as clients in real estate, venture backed start-up companies and service companies. Previously, Gary was a Director at a San Jose CPA firm providing comprehensive accounting services, including individual, corporate, and partnership taxation. Gary is a member of the American Institute of Certified Public Accountants and the California Society of Certified Public Accountants. He earned his Bachelor of Science in Accounting from San Jose State University.
Associate VP, Quality Assurance
Betsy GutierrezAssociate VP, Quality Assurance
Betsy Gutierrez has over 18 years of experience in areas of Quality Systems, Regulatory Compliance and Engineering in large organizations as well as in start-up environments. Prior to joining Rani, Betsy was the Sr. Director of Quality and Regulatory Affairs at Oraya Therapeutics. She has also held leadership positions of increasing responsibilities at Auxogy Inc., LuMend (a J&J company) and Edwards Lifesciences.
She has extensive experience in managing all aspects of the Quality Management Systems, Quality Engineering, Regulatory Compliance and Product Development support under US (FDA) and International (ISO) Regulations. Betsy holds a Bachelor of Science degree in Industrial Engineering and an MBA from Pontificia Universidad Catolica Madre y Maestra in the Dominican Republic.
Vice President, Regulatory Affairs
Mike BilligVice President, Regulatory Affairs
Mike serves as Vice President, Regulatory. In addition to his work with InCube, Mike is CEO of Experien Group, a clinical and regulatory consulting firm, which he co-founded in 2003. His entire 35+ year professional career has been involved with regulatory affairs, quality systems, clinical research, and general management for medical device companies. Mike has secured regulatory approval for hundreds of medical device products across the U.S., Europe, Canada, Central and South America, and Asia. Mike earned his BS degree in Microbiology from the University of Minnesota.
Director, Human Resources
Bella VazquezDirector, Human Resources
Bella has over 20 years of experience specializing in small to mid-size organizations. Her broad experience includes benefits, employee relations, payroll, talent acquisition, compliance reporting, HRIS Implementation, policy design, employee development and performance management.
Bella has extensive hands-on experience leading HR initiatives and providing innovative ways to engage employees and establishing company culture.
She has experience in various industries including professional services, technology and retail. She holds a Senior Professional in Human Resources certification (SPHR) and is a member of the Society for Human Resources Management (SHRM).
Syed ZaidiVice President
Syed is an industry veteran with more than 25 years of experience in accounting, HR and operations.
In his role at InCube, Syed has been instrumental in launching and running operations for more than a dozen start-ups in the last 15 years.
Syed received his MBA from Osmania University in Hyderabad, India.
We are focused on developing and commercializing disruptive innovations that solve problems in a new way and have the potential for big impact
We are committed as a team to work collaboratively together across disciplines to achieve common goals and advance our companies
We are motivated by our desire to improve the lives of millions of patients suffering from chronic disease
InCube’s innovation process has been developed over years of examining and understanding problems. After years of building companies, Mir evaluated his successes and failures, and devised a process for innovation. We focus on the big problems and developing disruptive innovations which can have a major impact on patients and markets. This focus is the lifeblood of our organization, and central to our work every day.
I am passionate about changing healthcare and coming up with new solutions that will impact the lives of millions of patients.
Mir Imran, Chairman & CEO
The Solution to Every Problem is Embedded in the Understanding of the Problem.
Mir Imran, Chairman & CEO
Innovation is the identification and definition of a problem that is worthy of solution.
Mir Imran, Chairman & CEO
In the pursuit of disruptive innovations…failure is a constant companion and success an occasional visitor.
Mir Imran, Chairman & CEO